The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Lipids changes in liver cancer

På svenska

Author

  • Jing-Ting Jiang
  • Ning Xu
  • Xiao-Ying Zhang
  • Chang-Ping Wu

Summary, in English

Liver is one of the most important organs in energy metabolism. Most plasma apolipoproteins and endogenous lipids and lipoproteins are synthesized in the liver. It depends on the integrity of liver cellular function, which ensures homeostasis of lipid and lipoprotein metabolism. When liver cancer occurs, these processes are impaired and the plasma lipid and lipoprotein patterns may be changed. Liver cancer is the fifth common malignant tumor worldwide, and is closely related to the infections of hepatitis B virus (HBV) and hepatitis C virus (HCV). HBV and HCV infections are quite common in China and other Southeast Asian countries. In addition, liver cancer is often followed by a procession of chronic hepatitis or cirrhosis, so that hepatic function is damaged obviously on these bases, which may significantly influence lipid and lipoprotein metabolism in vivo. In this review we summarize the clinical significance of lipid and lipoprotein metabolism under liver cancer.

Publishing year

2007

Language

English

Pages

398-409

Publication/Series

Journal of Zhejiang University-Science B

Volume

8

Issue

6

Document type

Journal article review

Publisher

Zhejiang University Press

Topic

  • Medicinal Chemistry
  • Pharmacology and Toxicology

Keywords

  • Lipids
  • Liver cancer
  • Lipoprotein

Status

Published

ISBN/ISSN/Other

  • ISSN: 1862-1783